Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for market hendrychova
Your search for Markéta Hendrychova retrieved no results
Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays.
O Salas C, Zarate AM, Kryštof V, Mella J, Faundez M, Brea J, Loza MI, Brito I, Hendrychová D, Jorda R, Cabrera AR, Tapia RA, Espinosa-Bustos C. O Salas C, et al. Int J Mol Sci. 2019 Dec 25;21(1):161. doi: 10.3390/ijms21010161. Int J Mol Sci. 2019. PMID: 31881717 Free PMC article.
Compound 7h was found to be an effective potential agent when compared with a currently marketed drug, cisplatin, in four out of the seven cancer cell lines tested. ...Finally, it was demonstrated that 7h induced apoptosis and caused cell cycle arrest at the S-phase …
Compound 7h was found to be an effective potential agent when compared with a currently marketed drug, cisplatin, in four out of the …
Consumption of osteoanabolic drugs and strontium ranelate in the treatment of osteoporosis in the Czech Republic in 2005-2011.
Fuksa L, Vytrisalova M, Hendrychova T, Hrubesova I, Vlcek J, Palicka V. Fuksa L, et al. Acta Pol Pharm. 2014 Mar-Apr;71(2):329-35. Acta Pol Pharm. 2014. PMID: 25272654 Free article.
The objective was to analyze trends in consumption of osteoanabolic and dual drugs in the treatment of osteoporosis since their introduction onto the market in CZ (2005-2011). The prescription-based database of the General Health insurance Company of the Czech Republic tha …
The objective was to analyze trends in consumption of osteoanabolic and dual drugs in the treatment of osteoporosis since their introduction …